Redox Joins Allscripts Developer Program to Extend Access to Full-Service Integration Platform

MADISON, Wis.–(BUSINESS WIRE)–Redox announced today that Allscripts® has certified the first global integration engine of the Allscripts Developer Program (ADP). All digital health vendors that are part of the Redox Network will automatically be eligible for Allscripts Unity API access and expedited implementation timelines offered by the ADP program. With over 235 digital health vendors using Redox today to integrate with healthcare organizations, this integration will increase the selection of vetted, easily integrated applications Allscripts clients can choose to implement through the ADP platform. Redox is a healthcare data platform that standardizes and simplifies how digital health vendors integrate and exchange data between healthcare delivery organizations and over 40 different electronic health record (EHR) vendors.

Redox provides a single, global connection to Allscripts Unity APIs that digital health vendors can use to integrate and exchange data with approved Allscripts client sites. This model has reduced implementation timelines by up to 70 percent compared to non-Unity API integrations. Furthermore, since Redox has already built global adaptors to the Unity API endpoints, developers of digital health solutions that are using the Redox platform can now deploy to Allscripts organizations with minimal development effort. Moving forward, Redox will offer vendors, who are just starting to offer solutions to the Allscripts client market, a streamlined path to accelerate the certification process by centralizing all API calls through Redox.

Provider organizations that use Allscripts TouchWorks® EHR, Allscripts Professional EHR™ and Allscripts Practice Management™ are also able to rapidly deploy digital health applications that are part of the Redox Network. The Redox Network supports vendors across dozens of verticals in healthcare technology, including telehealth, chronic care management, medical devices, population health and revenue cycle management.

“The Allscripts Unity APIs are an incredible asset to clinics and hospitals that rely on Allscripts for their EHR. Vendors that use Redox already have a consolidated integration experience, and we couldn’t be more excited to extend that experience to include a direct connection to Allscripts Unity API,” said Devin Soelberg, vice president, Business Development & Partnerships, Redox.

The Allscripts Developer Program (ADP) offers both proprietary and FHIR®-enabled APIs to connect third-party applications, devices and other innovative healthcare technologies with Allscripts products. Allscripts has been supporting API integration since 2007 and is enabling over a billion data exchanges each year – the largest documented utilization of APIs in healthcare.

About Redox

Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange healthcare data. With just one connection, data can be transmitted across a growing network of more than 500 healthcare delivery organizations and 236 independent software vendors.

Members of the Redox Network exchange more than seven million patient records per day, leveraging a single data standard compatible with more than 40 electronic health record systems. Learn how you can leverage the Redox Platform at www.redoxengine.com. Please follow us on Twitter and LinkedIn.

Contacts

Look Left Marketing

Davida Dinerman

press@redoxengine.com
508-561-4263

Staff

Recent Posts

For Pride Month, Mental Health Professionals Offer Parenting Help

Parenting is a hard job under the best of circumstances. It can be especially confusing…

2 hours ago

Curiteva Announces the Beginning of the Commercial Launch of the Inspire(R) Posterior Interbody Solutions

HUNTSVILLE, AL / ACCESSWIRE / June 19, 2024 / Curiteva, Inc., a leading technology and…

2 hours ago

Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically

TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. ("Theralase®" or the…

2 hours ago

Sharecare announces inducement grants under Nasdaq Listing Rule 5635(c)(4)

ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR), the digital health company that…

2 hours ago

Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association

Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people…

2 hours ago

Calibre Scientific Acquires DCS, a German Provider of Antibodies, Reagents and Equipment Used in Immunohistochemistry

LOS ANGELES, June 19, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the…

2 hours ago